About Us

Fact Sheets

President and CEO John Ducker
Corporate Headquarters Schaumburg, Illinois, USA
Number of Employees More than 1,800 throughout North America
Parent Company APP is a Fresenius Kabi company.
APP Vision To be the leading U.S./Canadian injectable pharmaceutical company, delivering excellence in our products and services with dedicated and committed employees to meet our customers’ needs and help improve the health and care of patients.
APP Products APP offers a single source for products ranging from the most frequently used to those products with specialized indications. The company markets more than 142 products in over 400 dosages and formulations. APP products are used in every area of clinical care, ranging from:
  • Cardiac Care
  • Dialysis
  • Emergency
  • Intensive Care
  • OB/GYN
  • Operating Room
  • Oncology
  • Orthopedics
  • Pediatrics
  • Psychiatry
  • Radiology
Market Position APP is the #3 generic injectable supplier in the United States, and is the only U.S. generic company with a dedicated cephalosporin injectable plant.*

* Source: IMS May 2011 (YTD November 2008). Total Market includes all delivery systems (e.g., vials, systems, etc.)
Manufacturing Facilities
  • Melrose Park, Illinois
  • Grand Island, New York
  • Raleigh, North Carolina
APP has the ability to manufacture a comprehensive range of products at each site including sterile powder, aseptic liquid and terminal sterilization.
Science, Production and Technology Center Skokie, Illinois
Countries Where
Products are Sold		 United States and Canada
Corporate Responsibility In response to the devastating earthquake in Haiti, APP Pharmaceuticals donated a range of cephalosporin antibiotics to treat nearly 175,000 patients suffering from wound and blood infections. A separate shipment of injectable drugs went to Haiti for use by surgeons, who were able to treat an additional 10,000 patients as a result of APP’s donation.